mRNA-4157,Pembrolizumab
Moderna,Merck
['melanoma', 'merck', 'moderna']
we re pleased to share late-breaking data with at #asco23 for our investigational individualized neoantigen therapy in combination with immunotherapy for #melanoma, as we continue to advance our oncology pipeline. learn more here: 
We aspire to be the premier research-intensive biopharmaceutical company. Intended for U.S. residents only. FLS: https://t.co/20VS9JL2y9